BRIACELL THERAPEUTICS CORP.
Ownership & governance
Executives 3Directors 6Avg age 64Avg tenure 7.7y
WW
William Williams
Chief Executive Officer
Age 70Since 2016-10-31Profile →
+8
Executives3
WW
William Williams→
Chief Executive Officer
Age 70Since 2016-10-31
GL
Gadi Levin
Director of Finance/CFO
Age 54Since 2016-01-31
GP
Guiseppe Del Priore
Chief Tech/Sci/R&D Officer
Age 65Since 2022-02-15
Board of directors6
WW
William Williams→
Director/Board Member
Age 70Since 2016-10-31
JB
Jamieson Bondarenko→
Chairman
Age 41Since 2019-04-23
RT
Rebecca Taub→
Director/Board Member
Age 73Since 2019-03-06
VE
Vaughn Embro-Pantalony→
Director/Board Member
Age 68Since 2019-03-17
MS
Martin Schmieg→
Director/Board Member
Age 63Since 2016-05-09
JG
Jane Gross→
Director/Board Member
Age 69Since 2022-01-17
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Citadel Advisors LLC | 9.885 % | 716,699 |
| Cable Car Capital LP | 2.99 % | 216,821 |
| Sabby Management LLC | 1.019 % | 73,915 |
| Iridian Asset Management LLC | 0.8965 % | 65,000 |
| William Williams | 0.4857 % | 35,218 |
Catalog · 2026-07-09
Proxy officers9
| Name | Role | Since | Shares |
|---|---|---|---|
| Jamieson Bondarenko | Chairman | 2019-04-23 | - |
| Giuseppe Del Priore, MD, MPH | Director or executive officer | — | 1,066 |
| Jamieson Bondarenko, CFA, CMT | Director or executive officer | — | 5,464 |
| Jane Gross | Director/Board Member | 2022-01-17 | - |
| Martin Schmieg | Director/Board Member | 2016-05-09 | - |
| Rebecca Taub | Director/Board Member | 2019-03-06 | - |
| Vaughn Embro-Pantalony | Director/Board Member | 2019-03-17 | - |
| William V. Williams, MD, FRCP | Director or executive officer | — | 3,748 |
Proxy · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus none
Broker actions10
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | 40 | 2025-08-27 |
| HC Wainwright & Co. | Reiterated | Buy | 32 | 2025-04-22 |
| HC Wainwright & Co. | Maintained | Buy | 32 | 2025-02-03 |
| HC Wainwright & Co. | Reiterated | Buy | 15 | 2024-12-12 |
| HC Wainwright & Co. | Reiterated | Buy | 15 | 2024-12-03 |
| HC Wainwright & Co. | Reiterated | Buy | 15 | 2024-10-03 |
| HC Wainwright & Co. | Maintained | Buy | 15 | 2024-09-19 |
| HC Wainwright & Co. | Reiterated | Buy | 18 | 2024-09-11 |
| HC Wainwright & Co. | Reiterated | Buy | 18 | 2024-06-04 |
| HC Wainwright & Co. | Reiterated | Buy | 18 | 2024-05-24 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.